Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.
LSTA
$1.31
+3.97%
LSTA
· Lisata Therapeutics, Inc.
$1.31
+0.05 (+3.97%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$14.24M
Shares
9.01M
Volume · Oct 5
90.75K
Avg daily vol (3M)
286.44K
All webcasts
Earnings call · FY2024 Q4
Lisata Therapeutics, Inc. (LSTA) Q4 2024 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$1.00M
Net income · derived Q4
-$4.61M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 27, 2025 · complete as-filed document